Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Integra Lifesciences (NQ: IART ) 31.34 +0.04 (+0.13%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 864,435 Open 31.48 Bid (Size) 30.55 (1) Ask (Size) 32.26 (1) Prev. Close 31.30 Today's Range 30.92 - 31.52 52wk Range 22.36 - 46.75 Shares Outstanding 84,579,542 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART Today 17:50 EDT From Kahn Swick & Foti, LLC Via Business Wire 8 Analysts Have This To Say About Integra Lifesciences July 15, 2024 Via Benzinga Performance YTD -27.54% -27.54% 1 Month +8.52% +8.52% 3 Month +9.27% +9.27% 6 Month -26.07% -26.07% 1 Year -29.65% -29.65% More News Read More For those who appreciate value investing, NASDAQ:IART is a compelling option with its solid fundamentals. July 03, 2024 Via Chartmill INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART June 24, 2024 From Kahn Swick & Foti, LLC Via Business Wire NASDAQ:IART appears to be flying under the radar despite its strong fundamentals. June 11, 2024 Via Chartmill A Glimpse Into The Expert Outlook On Integra Lifesciences Through 8 Analysts May 07, 2024 Via Benzinga Analyst Scoreboard: 5 Ratings For Integra Lifesciences February 29, 2024 Via Benzinga Recap: Integra Lifesciences Q4 Earnings February 28, 2024 Via Benzinga CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump June 07, 2024 Via Investor's Business Daily Topics Stocks Exposures US Equities $1.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying May 28, 2024 Via Benzinga NASDAQ:IART is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. May 08, 2024 Via Chartmill Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday May 06, 2024 Via Benzinga The Analyst Landscape: 7 Takes On Integra Lifesciences December 22, 2023 Via Benzinga The Latest Analyst Ratings for Integra Lifesciences December 05, 2023 Via Benzinga Stocks On Track For Third Green Session, Palantir Ignites Rally In Chipmakers, Commodities Rebound: What's Driving Markets Monday? May 06, 2024 Via Benzinga Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session May 06, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session May 06, 2024 Via Benzinga Why Is Medical Device Maker Integra LifeSciences Stock Falling On Monday? May 06, 2024 Via Benzinga IART Stock Earnings: Integra Lifesciences Meets EPS, Beats Revenue for Q1 2024 May 06, 2024 Via InvestorPlace SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART March 27, 2024 From Pomerantz LLP Via GlobeNewswire NASDAQ:IART is probably undervalued for the fundamentals it is displaying. March 25, 2024 Via Chartmill Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March March 07, 2024 Via Benzinga NASDAQ:IART, an undervalued stock with good fundamentals. March 04, 2024 Via Chartmill INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm December 14, 2023 From Bragar Eagel & Squire Via GlobeNewswire Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal December 13, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
